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r. Boyar would make a very creative accountant. He correctly
otes that there are downstream costs and benefits associated with
ny health care proposal but goes on to sweep the initial $11.3
illion cost of screening under the carpet, analyzing only the
dditional costs encountered during some future “steady state” (the
xistence of which necessitates a rather unlikely synchrony between
he number of subjects entering and leaving the group of test
andidates). This is equivalent to valuing the cost of driving only
y what you pay for gas while ignoring what you paid to buy the
ar. You can, of course, obtain a loan to amortize the car’s cost over
any years, but you are not going to get the same deal from your
ocal nuclear laboratory (Visa and MasterCard notwithstanding).
n general, health care is a cash-and-carry business in which
p-front costs must be paid up front. And if the testing itself were
pread out over time, the benefits would be similarly spread out.
ou can’t get something for nothing.
Are there other ways to cut these costs? Although it is unlikely
hat any nuclear laboratory would further discount the already
eavily discounted Medicare price of $800 used in our analysis (1),
tatins can be had for much less than our average wholesale price
f $2 per day. Drive over to the nearest Wal-Mart (you did buy
hat car, didn’t you?) and you can walk out with an entire month’s
upply for only $4. At that price, the annual cost of unconditional
reatment falls by over 90% from $10.1 billion to only $0.7illion—far less than any conditional strategy, even ignoring the
nitial cost of testing and the implied value of some metaphorical
warranty.” If that is not good enough, some health plans are
tarting to give statins away, believing that the long-term savings
ill more than offset the short-term costs (2). Maybe you can get
omething for nothing!
George A. Diamond, MD, FACC
anjay Kaul, MD, FACC
rediman K. Shah, MD, FACC
Division of Cardiology
edars-Sinai Medical Center
avid Geffen School of Medicine
niversity of California
408 Wild Oak Drive
os Angeles, California 90068
-mail: gadiamond@pol.net
doi:10.1016/j.jacc.2007.06.017
EFERENCES
. Diamond GA, Kaul S, Shah PK. Screen testing: cardiovascular preven-
tion in asymptomatic diabetic patients. J Am Coll Cardiol 2007;49:
1915–7.
. Fuhrmans V. New tack on copays: cutting them. Employers, insurers
bet that covering more of the cost of drugs can save money over the long
term for chronic conditions. Wall Street Journal. May 8, 2007:D1.
